# Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Prevention in a Malaysia Adult ICU

> **NCT05959018** · NA · COMPLETED · sponsor: **University of Malaya** · enrollment: 110 (actual)

## Conditions studied

- CLABSI - Central Line Associated Bloodstream Infection

## Interventions

- **DEVICE:** Arrow Three-Lumen Central Venous Catheter
- **DEVICE:** Arrowg+ard Blue Plus® Three-Lumen Central Venous Catheter

## Key facts

- **NCT ID:** NCT05959018
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-19
- **Primary completion:** 2026-03-03
- **Final completion:** 2026-03-03
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05959018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05959018, "Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Prevention in a Malaysia Adult ICU". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05959018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*